Loading
Total declarations
Companies
▲ Purchases (8 ops.)
▼ Sales (0 ops.)
Latest filing published 19 Mar 2021 for Neos Therapeutics, Inc..
Filing timeline
BuySaleAlan L. Heller
Insider track record
Disclosed buys
8
Disclosed sells
0
Signal history
Closed purchases
Market purchases
8
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Alan L. Heller: trading record in brief
This profile gathers the share dealings of Alan L. Heller across 4 companies, led by Savient Pharmaceuticals Inc, Neos Therapeutics, Inc. and Applied Neurosolutions Inc. In total, 32 filings cover trades dated from 24 February 2006 to 19 March 2021.
Purchases make up the whole of the open-market record (8 purchases, €233k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 18 share grants and 2 option exercises.
The median purchase comes to €13k.
On 19 March 2021 came the latest disclosure, a transaction in Neos Therapeutics, Inc. The most recent open-market purchase was published on 8 November 2018, 2,906 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Alan L. Heller
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations23 total
446,819 sharesCommon StockSEC:0001104659-21-039176:0
23,453 shares0Common StockSEC:0001104659-20-072548:0
43,478 shares@ US$2.30100.0% of flowCommon StockSEC:0001104659-18-066979:0
Canonical exit: 6 Feb 2019 (T+90)
10,000 shares@ US$7.6143.7% of flowCommon StockSEC:0001179110-16-025081:0
Canonical exit: 17 Aug 2016 (T+90)
16,408 shares@ US$0.024Common StockSEC:0001104659-15-053968:0
28,897 shares@ US$2.31Common StockSEC:0001104659-15-053968:1
1,643 shares@ US$0.32Common StockSEC:0001104659-15-053968:2
20,833 sharesCommon StockSEC:0001104659-15-053968:3
100,000 sharesCommon StockSEC:0001104659-15-053968:4
91,956 sharesCommon StockSEC:0001104659-15-053968:5
7,500 shares@ US$3.99Common Stock, $0.1 par value per shareSEC:0001181431-11-049678:0
Canonical exit: 14 Dec 2011 (T+90)
3,514 sharesCommon Stock, $.01 par value per shareSEC:0001181431-10-038098:0
13,044 shares0Common StockSEC:0001209191-09-001950:0
25,000 shares@ US$0.075Common StockSEC:0001140361-08-021179:0
Canonical exit: 8 Dec 2008 (T+90)
40,000 shares@ US$0.07Common StockSEC:0001140361-08-021191:0
Canonical exit: 9 Dec 2008 (T+90)
1,622 shares@ US$24.66Common Stock, $.01 par value per shareSEC:0001230295-08-000290:0
50,000 shares@ US$0.14Common StockSEC:0001140361-07-024501:0
Canonical exit: 16 Mar 2008 (T+90)
50,000 shares@ US$0.15Common StockSEC:0001140361-07-022382:0
Canonical exit: 14 Feb 2008 (T+90)
145 shares@ US$12.77Common Stock, $.01 par value per shareSEC:0001230295-07-000330:0
3,132 shares@ US$12.77Common Stock, $.01 par value per shareSEC:0001230295-07-000330:1
1,152 shares0Common StockSEC:0001209191-06-051307:0
10,000 shares@ US$5.49Common Stock, $.01 par value per shareSEC:0001230295-06-000120:0
Canonical exit: 23 Aug 2006 (T+90)
1,406 shares@ US$10.67Common Stock, par value $0.01SEC:0001209191-06-013913:0
23 of 23 declarations
